We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Developments at Olympus Diagnostica

By Labmedica staff writers
Posted on 20 Apr 2005
Print article
Olympus Diagnostica GmbH (Hamburg, Germany) has announced that the company has changed its name to Olympus Life & Material Science Europa GmbH, amalgamating the fields of diagnostics and microscopy.

In another new development, Olympus Life and Material Science Europa GmbH has acquired the privately held microfluidics company Advalytix AG (Brunnthal, Germany). Olympus states that the extremely broad application spectrum and innovative technologies of Advalytix will provide it with additional potential to nurture expansion and maximize business growth.

Microfluidics is a key technology for diagnostics and molecular biology research used to manipulate liquids in submicroliter range. The miniaturization of liquid volumes meets an ever-growing demand to conserve both scarce samples and expensive reagents. Advalytix, which developed the SlideBooster hybridization and AdvaWash washing stations, is also developing products and protocols for the genetic analysis of single cells.

"The acquisition of Advalytix represents great short-, mid-, and long-term opportunities for Olympus Life and Material Science,” noted Dr. Helmut Koehler, executive managing director of Olympus Life and Material Science. "It positions Olympus at the very forefront of the latest technological developments in life science and allows us to sustain our above-average growth as well as profiting from the future developments in this rapidly expanding specialist area.”

In another move, to increase floor space and handle future expansion, the research and development center of Olympus for immunoassays has been moved to Rungis, a technology area south of Paris (France). The center will be housed in the same building as the head office of the diagnostics division of Olympus France. Work in the laboratory will focus on the development of heterogeneous immunoassays for the new Olympus AU3000i immuno-analyzer to be released in November 2006.




Related Links:
Olympus Life & Material Science
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Free Human Prostate-Specific Antigen CLIA
LIAISON fPSA
New
Chemistry Analyzer
MS100

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.